Acadian Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,906,092
| Closed | -$2.79M | – | 1918 |
|
|
2023
Q2 | $2.79M | Sell |
2,906,092
-806,319
| -22% | -$797K | 0.01% | 615 |
|
|
2023
Q1 | $2.78M | Buy |
3,712,411
+155,868
| +4% | +$114K | 0.01% | 623 |
|
|
2022
Q4 | $1.31M | Buy |
3,556,543
+2,401,203
| +208% | +$1.01M | 0.01% | 776 |
|
|
2022
Q3 | $495K | Buy |
1,155,340
+1,072,862
| +1,301% | +$1.05M | ﹤0.01% | 990 |
|
|
2022
Q2 | $65K | Sell |
82,478
-339,389
| -80% | -$299K | ﹤0.01% | 1453 |
|
|
2022
Q1 | $543K | Buy |
421,867
+392,877
| +1,355% | +$362K | ﹤0.01% | 971 |
|
|
2021
Q4 | $36K | Buy |
+28,990
| New | +$51.8K | ﹤0.01% | 1535 |
|
|
2020
Q4 | – | Sell |
-12,317
| Closed | -$50K | – | 2391 |
|
|
2020
Q3 | $50K | Sell |
12,317
-473,182
| -97% | -$1.8M | ﹤0.01% | 1863 |
|
|
2020
Q2 | $1.64M | Sell |
485,499
-193,664
| -29% | -$564K | 0.01% | 793 |
|
|
2020
Q1 | $1.58M | Buy |
+679,163
| New | +$1.86M | 0.01% | 669 |
|
|
2017
Q4 | – | Sell |
-2,525
| Closed | -$36K | – | 1701 |
|
|
2017
Q3 | $36K | Buy |
+2,525
| New | +$22.8K | ﹤0.01% | 1148 |
|
|
2017
Q2 | – | Sell |
-662,529
| Closed | -$4.31M | – | 1643 |
|
|
2017
Q1 | $4.31M | Sell |
662,529
-153,892
| -19% | -$861K | 0.02% | 441 |
|
|
2016
Q4 | $3.62M | Sell |
816,421
-1,032,774
| -56% | -$4.33M | 0.02% | 471 |
|
|
2016
Q3 | $8.63M | Sell |
1,849,195
-895,239
| -33% | -$5.3M | 0.04% | 292 |
|
|
2016
Q2 | $18M | Buy |
2,744,434
+658,825
| +32% | +$4.66M | 0.09% | 187 |
|
|
2016
Q1 | $13.3M | Sell |
2,085,609
-433,153
| -17% | -$2.22M | 0.07% | 242 |
|
|
2015
Q4 | $15.2M | Buy |
2,518,762
+1,972,869
| +361% | +$11.3M | 0.08% | 240 |
|
|
2015
Q3 | $3.26M | Buy |
+545,893
| New | +$3.79M | 0.02% | 465 |
|
Acadian Asset Management's SPPI Position: Q3 2023 in Review
Acadian Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 2,906,092 shares — an estimated $2.79M sold.
Acadian Asset Management first reported a position in SPPI in Q3 2015 and held it in 18 quarters. The position peaked at $18M in Q2 2016. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Acadian Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Acadian Asset Management sold 2,906,092 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $2.79M.
- Acadian Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2015 and held it in 18 quarters.
- Acadian Asset Management's Spectrum Pharmaceuticals Inc position peaked at $18M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.